Pharma channel feed

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

5 months ago
Deals
China

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

5 months ago
Deals

Jazz Phar­ma­ceu­ti­cals CEO and co-founder Bruce Cozadd is re­tir­ing

5 months ago
People

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

5 months ago
Law
Health Tech

San­doz inks $275M set­tle­ment in gener­ic an­titrust lit­i­ga­tion

5 months ago
Law

Pfiz­er’s mes­sage to in­vestors: The ship is steady­ing in 2025 (even if Wash­ing­ton is tur­bu­lent)

5 months ago
FDA+

How a du­ty to spend wise­ly on work­er ben­e­fits could loosen PBM­s' grip on drug prices

5 months ago
In Focus
Law

FDA re­jects J&J’s sub­cu­ta­neous Ry­bre­vant over man­u­fac­tur­ing is­sues

5 months ago
Manufacturing

As­traZeneca is de­nied full FDA ap­proval of An­dexxa fol­low­ing crit­i­cal ad­vi­so­ry meet­ing

5 months ago
FDA+

Virid­i­an read­ies for Te­pez­za ri­val­ry with new Phase 3 da­ta in thy­roid eye dis­ease

5 months ago
R&D

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

5 months ago
Deals

HRSA push­es back against an­oth­er 340B re­bate mod­el, this time from Sanofi

5 months ago
FDA+

Neu­ro­crine gets FDA go-ahead to treat rare adren­al gland con­di­tion

5 months ago
FDA+

Check­point wins FDA ap­proval of check­point in­hibitor in ad­vanced skin can­cer, seeks part­ner for launch

5 months ago
FDA+

Organon's steroid-free cream Vta­ma wins ap­proval in atopic der­mati­tis

5 months ago
FDA+

McK­in­sey hit with a $650M fine for de­ceiv­ing US about opi­oid con­sult­ing work

5 months ago
Law

FDA stands by mifepri­s­tone safe­ty la­bel in fed­er­al court chal­lenge

5 months ago
FDA+
Law

Bi­cy­cle Ther­a­peu­tics stock sinks fol­low­ing re­lease of topline da­ta, post-hoc analy­ses

5 months ago
R&D

EMA's com­mit­tee says ex­pand­ed la­bel for Lil­ly's Moun­jaro in­to sleep ap­nea not nec­es­sary

5 months ago
FDA+

CDK4 in­hibitors from BeiGene and Pfiz­er, ALX’s CD47 drug take the stage at SABCS

5 months ago
R&D

Ab­b­Vie makes an­oth­er small I&I ac­qui­si­tion, buy­ing Nim­ble for $200M

5 months ago
Startups
Deals

Safe­ty con­cerns and tri­al holds for pe­di­atric RSV vac­cines prompt cau­tion from FDA ad­comm

5 months ago
R&D
FDA+

'Se­ri­ous liv­er in­jury' cas­es lead FDA to call for mon­i­tor­ing of Ocali­va pa­tients

5 months ago
FDA+

Hand­ful of 'un­sup­port­ed' drug price in­creas­es added $800M to US costs, ICER claims

5 months ago
First page Previous page 20212223242526 Next page Last page
A service from the Financial Times